Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
NKTX
NKTX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NKTX News
GT Biopharma Advances NK Cell Therapy with TriKE Platform
Jun 12 2026
Globenewswire
GT Biopharma Advances NK Cell Therapy with TriKE Platform
Jun 12 2026
Newsfilter
GT Biopharma Advances Three Drug Candidates into Clinical Trials
Jun 08 2026
Globenewswire
GT Biopharma Advances Three Cancer Drug Candidates into Clinical Trials
Jun 08 2026
Newsfilter
GT Biopharma: Three Drugs Enter Human Trials
May 29 2026
PRnewswire
GT Biopharma Advances Three Drug Candidates in Clinical Trials
May 29 2026
Newsfilter
GT Biopharma Advances NK Cell Immunotherapy with TriKE Candidates
May 19 2026
Newsfilter
Nkarta Reaches FDA Agreement to Optimize Clinical Trials
Apr 16 2026
seekingalpha
Nkarta Reaches Agreement with FDA to Optimize Clinical Trials for NKX019
Apr 15 2026
Newsfilter
Nkarta Files $350M Mixed-Securities Offering to Fund Growth
Mar 26 2026
seekingalpha
Nkarta Q4 Earnings Miss Expectations
Mar 25 2026
seekingalpha
NKARTA REPORTS Q4 NET LOSS OF USD 27.408 MILLION
Mar 25 2026
moomoo
NKARTA Reports Q4 Basic EPS of USD -0.37
Mar 25 2026
moomoo
ImmunityBio Shares Triple in Three Weeks, Short-Sellers Face $500 Million Loss
Jan 21 2026
Yahoo Finance
Nkarta (NKTX) Participates in Evercore 8th Annual Healthcare Conference to Showcase NK Cell Therapy Progress
Dec 02 2025
Globenewswire
Nkarta to Attend Investor Conferences in November
Oct 30 2025
Newsfilter
Show More News
